
Keywords: FCH; fold change; FDR; false discovery rate; GSVA; gene-set variation analysis; JAK; Janus kinase; PASI; Psoriasis Area and Severity Index; TH17; T helper type 17; TNF; tumor necrosis factor; TRANCE; tumor necrosis factor-related activation-induced cyto